Clinical Trial Update: A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma [Phase 1]

View source ↗

Summary

A Phase I trial of a humanized anti-GD2 antibody in children and adolescents with neuroblastoma, osteosarcoma, Ewing sarcoma, and melanoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Melanoma
• Neuroblastoma
• Osteosarcoma

Drugs mentioned

• humanized anti-GD2 antibody

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Neuroblastoma, Melanoma | Phase 1 | Status: COMPLETED